Mandate

Vinge advises Alder in connection with its new majority ownership in Powerbox International

August 30, 2013

Powerbox International is one of Europe's leading manufacturers and distributors of power converters and associated products. It now has a new majority owner in Alder, a private equity fund based in Stockholm, Sweden. Founded in 1974, Powerbox International develops, manufactures and markets power supply solutions in AC/DC or DC/DC, ranging from a few watts to tens of kilowatts for demanding applications and customers. The company has an international reach with subsidiaries in 16 countries in Europe, the US and the Asia/Pacific region.

Alder is the new majority owner, with Industrifonden as well as current and previous employees of the company remaining as minority shareholders. Alder is an active investor and will, together with management, develop the company so that it reaches its full potential. As part of the transaction, new capital is invested in the company to help strengthen the organisation to enable future growth.

Vinges team consisted primarily of partners Johan Larsson and Jonas Bergström and associates Gustav Jönsson, Linn Adelwald and Philip Watson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025